You are currently viewing a new version of our website. To view the old version click .

Findings, Insights and Perspectives on Central Nervous System Tumors

Topic Information

Dear Colleagues,

Central nervous system (CNS) cancers are neoplastic diseases stemming from the brain and its surrounding structures, with increasing incidence, and high mortality and morbidity rates worldwide. They are characterized by their aggressive nature, marked heterogeneity and adaptation to chemoresistance, leading to a poor prognosis and clinical outcome. With the ongoing advances in research, the medical field is trying to abandon the “one size fits all” philosophy and adopt a personalized medicine approach, developing novel drug and formulation strategies that can target specific disease biomarkers. The aim of this topic is to provide a forum for researchers and clinicians to share their latest findings, insights, and perspectives on CNS tumors. We welcome original research and review articles on a range of topics related to CNS neoplasms, including, but not limited to, the following: (1) the molecular and cellular mechanisms of cancer initiation, progression, and resistance; (2) advances in diagnosis and treatment; (3) novel drug delivery strategies for cancer therapy; (4) new diagnostic and prognostic biomarkers; (5) innovative 3D microphysiological models for cancer and tumor microenvironment research; and (6) the synergy of machine learning in designing more efficient therapies.

Dr. João Basso
Dr. Carla Vitorino
Dr. Rui Vitorino
Dr. Ana Fortuna
Topic Editors

Keywords

  • artificial intelligence
  • biomarkers
  • brain cancer
  • drug delivery
  • drug repurposing
  • glioblastoma
  • molecular signatures
  • nanomaterials
  • organoids
  • targeted therapy

Participating Journals

Cancers
Open Access
33,745 Articles
Launched in 2009
4.4Impact Factor
8.8CiteScore
20 DaysMedian Time to First Decision
Q2Highest JCR Category Ranking
Cells
Open Access
19,362 Articles
Launched in 2012
5.2Impact Factor
10.5CiteScore
16 DaysMedian Time to First Decision
Q2Highest JCR Category Ranking
Diseases
Open Access
1,436 Articles
Launched in 2013
3.0Impact Factor
3.7CiteScore
23 DaysMedian Time to First Decision
Q2Highest JCR Category Ranking
Nanomaterials
Open Access
21,208 Articles
Launched in 2010
4.3Impact Factor
9.2CiteScore
15 DaysMedian Time to First Decision
Q2Highest JCR Category Ranking
Pharmaceutics
Open Access
13,386 Articles
Launched in 2009
5.5Impact Factor
10.0CiteScore
15 DaysMedian Time to First Decision
Q1Highest JCR Category Ranking

Published Papers